• Our Strength and New Modalities

    We are not only following conventional ways of drug discovery, but also seeking for new modalities for future medicine.

    more
  • What We Are Focusing On

    We are focusing on infectious diseases and pain/CNS disorders as core therapeutic areas to create innovative medicines. We are also studying on geriatric diseases and other frontier areas.

    more
  • Care for Environment, Health and Safety

    We have built up a company-wide management system based on the Shionogi Group EHS Policy, whose EHS activities embrace not only the Group but also its supplier partners.

    more
  • Facilities, Collaborations and IP Strategy

    In research, the Shionogi Pharmaceutical Research Center (SPRC), the center of the Shionogi Group’s research functions, has continued to serve as a platform through which we have further strengthened the coordination and productivity of our drug discovery.

    more